BIOHLDG

Quarterly rpt on consolidated results for the financial period ended 30 Sep 2024

Amended Announcements
Please refer to the earlier announcement reference number: FRA-29112024-00019

BIOALPHA HOLDINGS BERHAD

Financial Year End 31 Dec 2024
Quarter 3 Qtr
Quarterly report for the financial period ended 30 Sep 2024
The figures have not been audited

Remarks :
This announcement supersedes the earlier announcement made on 29 November 2024. Please note that amendments have been made to the following:
1) basic earnings per share, which should now be referred to as loss per share.
2) Net assets per share attributable to ordinary equity holders of the parent as at preceding financial year end should read as 0.1028 instead of 0.0879.
  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2024

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30 Sep 2024
30 Sep 2023
30 Sep 2024
30 Sep 2023
MYR'000
MYR'000
MYR'000
MYR'000
1 Revenue
34,934
11,720
65,118
28,717
2 Profit/(loss) before tax
-6,313
-2,713
-20,600
-23,086
3 Profit/(loss) for the period
-6,348
-2,760
-20,639
-23,283
4 Profit/(loss) attributable to ordinary equity holders of the parent
-5,597
-2,194
-19,888
-22,717
5 Basic earnings/(loss) per share (Subunit)
-0.40
-0.16
-1.41
-1.64
6 Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.00
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent
0.0879
0.1028

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence




Announcement Info

Company Name BIOALPHA HOLDINGS BERHAD
Stock Name BIOHLDG
Date Announced 03 Dec 2024
Category Financial Results
Reference Number FRA-02122024-00004